Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
   11  Agents affecting central nervous system
     111  General anesthetics
     112  Hypnotics and sedatives, anxiolytics
     113  Antiepileptics
     114  Antipyretics and analgesics, anti-inflammatory agents
     115  Stimulants
     116  Antiparkinsonian agents
     117  Psychotropics
       1171  Chlorpromazines
       1172  Phenothiazines
         D01520  Levomepromazine hydrochloride (JAN/USAN)
         D02248  Levomepromazine maleate (JP17/USAN)
         D00793  Fluphenazine decanoate (JAN/USP)
         D02163  Fluphenazine maleate (JAN)
         D00503  Perphenazine (JP17/USP/INN)
         D02037  Perphenazine maleate (JP17)
         D04038  Perphenazine fendizoate (JAN)
         D04965  Perphenazine hydrochloride
         D00479  Prochlorperazine maleate (JP17/USP)
         D02022  Prochlorperazine mesilate (JAN)
         D01485  Propericiazine (JAN)
N05AA02
N05AA02
N05AB02
N05AB02
N05AB03
N05AB03
N05AB03
N05AB03
N05AB04
N05AB04
N05AC01
       1173  MAO inhibitors
       1174  Imipramines
       1179  Others
     118  Common cold drugs
     119  Miscellaneous
   12  Agents affecting peripheral nervous system
   13  Agents affecting sensory organs
   19  Other agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: November 12, 2020
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version